Project Grant R01CA303291
- Federal Project Grant Award Summary Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $197,414 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398) on August 7, 2025, with completion targeted for July 31, 2030. This award supports a K01 (Mentored Research Development) grant designed to develop an early-career investigator's research capacity and expertise in studying dyadic and social network influences...
- Federal Grant Award Summary Rutgers The State University of New Jersey, Robert Wood Johnson Medical School (RBHS-School of Nursing) received a $222,749 Project Grant from the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398) awarded August 1, 2025, with completion targeted for July 31, 2030. The award supports the development and pilot testing of a digital single-session intervention (SSI) designed to reduce psychological distress in adolescent siblings of...
- Federal Grant Award Summary Rutgers The State University of New Jersey, through its School of Nursing located in Newark, NJ, received a $672,960 Project Grant from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), effective June 1, 2026, through May 31, 2031. The award funds research to understand the implications of EP300 (E1A Binding Protein) deficiency in Adult T-Cell Leukemia/Lymphoma (ATLL), a rare but aggressive T-cell malignancy caused by Human...
- Federal Grant Award Summary Award Overview The National Cancer Institute (NCI) awarded a Project Grant of $542,316 to Rutgers The State University of New Jersey, RBHS-School of Nursing, effective May 7, 2026, through April 30, 2031, under the Cancer Treatment Research program (CFDA 93.395). The research project, titled "The Mechanism and Therapeutic Potential of Parkin in Colorectal Cancer," investigates the role of the E3 ubiquitin ligase parkin in colorectal cancer (CRC)...
- Grant Award Summary The National Cancer Institute awarded Rutgers The State University of New Jersey (RBHS-School of Nursing) a Project Grant totaling $516,808 under the Cancer Treatment Research program (CFDA 93.395) effective June 1, 2026, through May 31, 2031. This five-year project investigates the mechanism by which methionine synthase (MTR) targeting enhances anti-tumor immunity in KRAS-driven non-small cell lung cancer (NSCLC). The research employs laboratory-based investigations and...
- Federal Grant Award Summary Rutgers, The State University of New Jersey, School of Nursing (RBHS-School of Nursing) received a $170,930 Project Grant from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396) to conduct research on the longitudinal dynamics of blood microbiome and circulating tumor cells (CTCs) in metastatic breast cancer. The award, effective April 1, 2026, through March 31, 2028, supports fundamental cancer biology research aimed at...
- Federal Grant Award Summary Rutgers The State University of New Jersey, Robert Wood Johnson Health Sciences (RBHS)-School of Nursing received a $403,689 Project Grant award from the National Cancer Institute (NCI) effective August 1, 2025, through July 31, 2027, under the Cancer Cause and Prevention Research program (CFDA 93.393). The grant funds research investigating the influence of menthol cigarette smoking on lung cancer screening eligibility within a national prospective cohort study....
- Federal Grant Award Summary Rutgers The State University of New Jersey, Robert Wood Johnson School of Nursing received a $861,930 Project Grant from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research Program (CFDA 93.394), awarded August 7, 2025, with a completion date of July 31, 2028. The award funds development and testing of a dyadic digital skin cancer prevention intervention targeting adolescents and their parents. The intervention leverages smartphone...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Sloan-Kettering Institute for Cancer Research a $731,503 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) effective June 1, 2026 through May 31, 2031. This grant funds a randomized controlled trial (RCT) evaluating Brief Behavioral Activation (BBA) as a telehealth-delivered intervention for treating depression in older adult cancer survivors (OACS) aged 65 and older. The research addresses a...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded Rutgers The State University of New Jersey – Robert Wood Johnson Medical School (RBHS) School of Nursing a $687,511 Project Grant on August 14, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a randomized controlled trial examining charcoal-filtered cigarettes, specifically the Natural American Spirit brand's "Sky" product. The five-year project, extending through...
Project Grant Summary The National Cancer Institute (NCI) awarded Rutgers The State University of New Jersey, School of Nursing, a $599,978 Project Grant effective July 1, 2026, through June 30, 2031, under the Cancer Cause and Prevention Research program (CFDA 93.393). This R01 grant from an Early Stage Investigator supports a prospective cohort study examining the relationship between perceived social obligations and treatment decisions among 315 patients with advanced, poor-prognosis cancer. The research addresses a clinical problem wherein patients with limited life expectancy consent to disease-directed chemotherapy and other toxic treatments that may cause more harm than benefit, driven by perceived social pressures to continue fighting their disease and maintain appearances for family and caregivers. The grant funds three integrated research aims: Aim 1 will measure associations between patient-reported social obligations and patient-centered outcomes at 3-month follow-up, including sense of peace, emotional struggle, and end-of-life preparedness; Aim 2 will examine health-service utilization outcomes, including hospitalization rates and receipt of intensive treatments in the final 30 days of life; and Aim 3 will employ mixed methods to characterize how social obligations are experienced and manifest in clinical interactions with family members and healthcare providers. Deliverables include prospective longitudinal data, quantitative outcome measures, 12-month follow-up assessments on hospice use and treatment intensity, and qualitative findings describing the mechanisms through which perceived social obligations influence end-of-life care decisions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $600.0k | 6/22/26 |